Jaguar Health, Inc. (NASDAQ:JAGX) Short Interest Update

Jaguar Health, Inc. (NASDAQ:JAGX) was the recipient of a significant increase in short interest in November. As of November 15th, there was short interest totalling 430,700 shares, an increase of 29.6% from the October 31st total of 332,300 shares. Based on an average trading volume of 266,600 shares, the days-to-cover ratio is presently 1.6 days. Approximately 5.6% of the shares of the stock are short sold.

Hedge Funds Weigh In On Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC purchased a new stake in Jaguar Health, Inc. (NASDAQ:JAGX) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.28% of Jaguar Health as of its most recent SEC filing. 12.04% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Jaguar Health from a “sell” rating to a “hold” rating in a research report on Friday, September 13th.

Jaguar Health Stock Performance

Jaguar Health stock opened at $1.04 on Monday. Jaguar Health has a 1 year low of $0.90 and a 1 year high of $24.30. The firm’s 50 day moving average price is $1.12 and its two-hundred day moving average price is $2.46. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.